Table 6: Clinical outcomes at two years.

ItalySpainSweden
Doxorubicin/ifosfamideTrabectedinDoxorubicin/ifosfamideTrabectedinDoxorubicin/ifosfamideTrabectedin

Probability of
 complete response0.01<0.01<0.01<0.01<0.010.01
 partial response0.01<0.010.01<0.010.010.01
 stable disease0.020.010.020.010.020.01
 progressive disease0.540.510.540.530.540.59
 dying0.430.470.420.450.420.39
Number of QALYs per patient0.595 (0.593, 0.597)0.530 (0.528, 0.533)0.590 (0.587, 0.593)0.550 (0.547, 0.553)0.608 (0.606, 0.611)0.584 (0.582, 0.587)

95% confidence intervals in parentheses.